Research

• The Department of Behavioral Medicine and Psychiatry is part of the WVU Rockefeller Neuroscience Institute (RNI).
  • Dr. Wanhong Zheng is the Vice Chair of Research for the Department of Behavioral Medicine and Psychiatry.
• Faculty and staff in the department have basic and clinical research grants, as well as service and training grants. Our faculty, staff and trainees collaborate with investigators and scientists from the WVU Health Sciences Center, the West Virginia Clinical and Translational Science Institute, the broader WVU system and others in the community.
• Quality improvement projects and training is available through the Center of Excellence for Addiction Medicine, which is part of the Department of Behavioral Medicine and Psychiatry.

Research Inquiries

If you are seeking research-related support (e.g. proposal preparation/submission, finding funding opportunities, initializing IRB process, and any type of WVU+kc submission) from the department’s Pre-Award Grants Administrator, please fill out the Research Inquiry Form.

Fill out the Research Inquiry Form

Current Externally Funded Research Projects

• A Feasibility Clinical Trial of Exablate for Low Intensity Focused Ultrasound Neuromodulation in Patients with Opioid Use Disorder

  • Principal Investigator: Ali Rezai, MD
  • Affiliated Faculty: Marc Haut, PhD; James Mahoney, PhD

• Appalachian Node of the NIDA Clinical Trials Network (CTN)

  • Principal Investigator: Judith Feinberg, MD
  • Affiliated Faculty: Laura Lander, MSW

  WVU is currently participating in the following NIDA CTN studies:

  1. Emergency Department-INitiated bupreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION) (CTN-0099)
     • Site: WVU Berkeley Medical Center
  2. Optimizing Retention, Duration, and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (CTN-0100)
     • Site Principal Investigator: Laura Lander, MSW
     • Site: WVU Chestnut Ridge Center
  3. Buprenorphine Treatment Engagement and Induction Problems Among Individuals Using Fentanyl (CTN-135)
     • Multiple Principal Investigators: Erin L. Winstanley, PhD

• Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory OUD

  • Principal Investigator: Ali Rezai, MD
  • Affiliated Faculty: Marc Haut, PhD; James Mahoney, PhD

• Off-Label Use of Rapid Response Fentanyl Test Strips as an Overdose Prevention Strategy

  • Principal Investigator: Judith Feinberg, MD

• Tailored Retention and Engagement for Equitable Treatment of OUD and Pain (TREETOP)

  • Site Principal Investigator: Erin L. Winstanley, PhD